VLDLR Antikörper (AA 133-247)
-
- Target Alle VLDLR Antikörper anzeigen
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
-
Bindungsspezifität
- AA 133-247
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VLDLR Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Very low-density lipoprotein receptor protein (133-247AA)
- Isotyp
- IgG
- Top Product
- Discover our top product VLDLR Primärantikörper
-
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 484-510) antibody
VLDLR Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB21297 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 551-650) antibodyVLDLR Reaktivität: Human, Maus WB, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 418-722) antibodyVLDLR Reaktivität: Human WB, ELISA, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) antibodyVLDLR Reaktivität: Human, Ratte, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (C-Term) antibodyVLDLR Reaktivität: Human, Ratte IHC, ISt, StM Wirt: Maus Monoclonal VLDLR-1337 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) antibodyVLDLR Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 1H10 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (AA 608-642) antibodyVLDLR Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB53886 unconjugated
anti-Very Low Density Lipoprotein Receptor (VLDLR) (C-Term) antibodyVLDLR Reaktivität: Human, Ratte ELISA, Coat Wirt: Kaninchen Monoclonal VLDLR-2896R unconjugated Recombinant Antibody
-
- Applikationshinweise
- Recommended dilution: IHC:1:200-1:500, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
- Andere Bezeichnung
- VLDLR (VLDLR Produkte)
- Hintergrund
-
Background: Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity).
Aliases: FLJ35024 antibody, Very low density lipoprotein receptor antibody, Very low-density lipoprotein receptor antibody, VLDL R antibody, VLDL receptor antibody, VLDL-R antibody, VLDLR antibody, VLDLR_HUMAN antibody, VLDLRCH antibody
- UniProt
- P98155
- Pathways
- Cellular Response to Molecule of Bacterial Origin
-
